Weill Medical College Of Cornell University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1865-01-01

Employees: -

Market Cap: -

Website: http://weill.cornell.edu

Clinical Trials

Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy

Phase 1

Completed

Conditions: Non-Hodgkin's Lymphoma

Interventions: Drug: bortezomib, tositumomab

First Posted Date: 2008-10-22

Last Posted Date: 2018-08-13

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 31

Registration Number: NCT00777114

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States
🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP

Phase 2

Completed

Conditions: Immune Thrombocytopenic Purpura

Interventions: Drug: Rituxan, Cyclophosphamide, Vincristine, Prednisone
Drug: Higher Dose of Rituximab

First Posted Date: 2008-10-17

Last Posted Date: 2019-01-09

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 17

Registration Number: NCT00774202

Locations: 🇺🇸
525 East 68th Street, New York, New York, United States

Impact of Vendor Systems on Ambulatory Medication Safety

Completed

Conditions: Medication Errors

Interventions: Other: Electronic prescribing

First Posted Date: 2008-10-16

Last Posted Date: 2012-02-28

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 20

Registration Number: NCT00773500

Locations: 🇺🇸
New York City Department of Health and Mental Hygiene, New York, New York, United States
🇺🇸
Taconic IPA, Fishkill, New York, United States

The Effect of Intravenous Anesthetics on Fear Learning and Memory

Not Applicable

Completed

Conditions: Phobias

Interventions: Drug: Propofol 0.90mcg/mL
Drug: Thiopental 1.5mcg/mL
Drug: Thiopental 3mcg/mL
Drug: Propofol 0.45mcg/mL
Drug: Placebos

First Posted Date: 2008-10-07

Last Posted Date: 2019-05-15

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 67

Registration Number: NCT00767767

Locations: 🇺🇸
Weill Cornell Medical College/New York Presbyterian Hospital, New York, New York, United States

Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP)

Phase 4

Conditions: Spontaneous Bacterial Peritonitis
Cirrhosis

Interventions: Drug: Standard Care
Drug: Experimental

First Posted Date: 2008-09-29

Last Posted Date: 2011-01-04

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 80

Registration Number: NCT00761098

Locations: 🇺🇸
New York Presbyterian Hospital - Weill Cornell Medical Center, New York, New York, United States
🇺🇸
New York Presbyterian Hospital - Columbia University Medical Center, New York, New York, United States

A Phase III Study of En Bloc Versus Non-En Bloc Esophagectomy in Esophageal Cancer

Phase 3

Terminated

Conditions: Esophageal Neoplasms

Interventions: Procedure: Esophagectomy

First Posted Date: 2008-09-26

Last Posted Date: 2012-08-13

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 4

Registration Number: NCT00760604

Locations: 🇺🇸
Weill Medical College of Cornell Unversity, New York, New York, United States

Treatment Response of Geriatric Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Drug: Escitalopram

First Posted Date: 2008-09-18

Last Posted Date: 2019-03-19

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 106

Registration Number: NCT00754936

Locations: 🇺🇸
Weill Cornell Medical College-Westchester Division, White Plains, New York, United States

Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)

Completed

Conditions: Diffuse Large B-cell Lymphoma

First Posted Date: 2008-09-17

Last Posted Date: 2018-05-29

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 8

Registration Number: NCT00754117

Locations: 🇺🇸
Weill Cornell Medical College, New York, New York, United States

MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions

Not Applicable

Completed

Conditions: Myelodysplastic Syndrome (MDS)

Interventions: Other: T2* Cardiac and Liver MRI

First Posted Date: 2008-09-09

Last Posted Date: 2018-10-25

Lead Sponsor: Weill Medical College of Cornell University

Target Recruit Count: 15

Registration Number: NCT00749372

Locations: 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States

Rifaximin Versus Lactulose in Renal Failure

Phase 4

Withdrawn

Conditions: Renal Failure
Liver Cirrhosis

Interventions: Drug: Rifaximin
Drug: Lactulose

First Posted Date: 2008-09-09

Last Posted Date: 2022-02-08

Lead Sponsor: Weill Medical College of Cornell University

Registration Number: NCT00748904

Locations: 🇺🇸
Weill Cornell Medical Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy